The Trulicity design improves convenience, particularly for anyone with needle-phobia, and raises the bar for effective GLP-1 agonist delivery we think many will start taking GLP-1 as a result of the launch
Maybe I'll ramp it up to four
What the FDA Is Doing and What Changes for Patients Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025, which removed the legal basis for compounding copies of the approved drugs
ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
Safe B12 Dosing and Monitoring for Older People Establishing appropriate B12 dosing for elderly patients requires consideration of the underlying cause of deficiency, severity of symptoms, and individual patient factors
Red blood cell stiffness and adhesion are species-specific properties strongly affected by temperature and medium changes in single cell force spectroscopy